Bath & Body Works (NYSE:BBWI - Get Free Report) had its price objective reduced by analysts at Robert W. Baird from $23.00 to $22.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has a "neutral" rating on the stock. Robert W. Baird's target price suggests a potential upside of 16.19% from the stock's current price.
Several other analysts have also recently weighed in on BBWI. Citigroup raised Bath & Body Works from a "neutral" rating to a "buy" rating and set a $25.00 price target for the company in a report on Tuesday, August 18th. Wells Fargo & Company increased their price objective on Bath & Body Works from $24.00 to $25.00 and gave the stock an "overweight" rating in a research report on Thursday, October 29th. UBS Group lifted their target price on Bath & Body Works from $17.00 to $22.00 and gave the stock a "neutral" rating in a report on Friday, November 13th. Jefferies Financial Group reissued a "hold" rating and set a $21.00 target price on shares of Bath & Body Works in a report on Thursday. Finally, Argus reissued a "hold" rating on shares of Bath & Body Works in a research report on Wednesday, September 16th. Three investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $22.33.
View Our Latest Stock Report on BBWI
Bath & Body Works Stock Up 1.5%
Bath & Body Works stock opened at $18.93 on Friday. The company's 50-day moving average price is $19.24 and its two-hundred day moving average price is $19.77. The stock has a market cap of $3.82 billion, a P/E ratio of 4.93, a P/E/G ratio of 0.93 and a beta of 1.31. Bath & Body Works has a twelve month low of $14.27 and a twelve month high of $24.94.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, November 19th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.12 by $0.14. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The company had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.55 billion. During the same quarter in the previous year, the company posted $0.37 earnings per share. The business's revenue was down 1.1% on a year-over-year basis. Bath & Body Works has set its Q4 2026 guidance at 1.410-1.610 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Equities analysts anticipate that Bath & Body Works will post 2.74 earnings per share for the current fiscal year.
Institutional Trading of Bath & Body Works
A number of institutional investors have recently modified their holdings of the stock. Algert Global LLC increased its position in shares of Bath & Body Works by 36.0% in the third quarter. Algert Global LLC now owns 684,287 shares of the company's stock worth $10,894,000 after purchasing an additional 181,023 shares during the period. Ancora Advisors LLC lifted its position in Bath & Body Works by 107,891.7% during the third quarter. Ancora Advisors LLC now owns 12,959 shares of the company's stock worth $206,000 after purchasing an additional 12,947 shares during the period. Readystate Asset Management LP grew its stake in Bath & Body Works by 408.8% during the third quarter. Readystate Asset Management LP now owns 579,712 shares of the company's stock worth $9,229,000 after buying an additional 465,780 shares in the last quarter. Ares Systematic Credit Ltd acquired a new stake in Bath & Body Works during the third quarter worth about $442,000. Finally, Saba Capital Management L.P. grew its stake in Bath & Body Works by 784.2% during the third quarter. Saba Capital Management L.P. now owns 84,111 shares of the company's stock worth $1,339,000 after buying an additional 74,598 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.
Latest Bath & Body Works News
Investors following BBWI have been watching these news items:
- Positive Sentiment: Third-quarter adjusted earnings of $0.26 per share topped the $0.12 consensus estimate, while revenue of $1.58 billion also exceeded expectations. The company raised its full-year sales outlook, now projecting a decline of 3.4% to 2.1%. Q3 results and outlook
- Neutral Sentiment: A limited-edition holiday fragrance collection with Pantone adds a new gifting and home-products offering, though its sales impact is not yet clear. Pantone holiday collection
- Negative Sentiment: Investors face a weaker near-term outlook: fourth-quarter EPS guidance of $1.41–$1.61 is below the $1.72 analyst consensus, and the company warned of softer holiday sales. Third-quarter revenue was down about 1% year over year, and EPS was below the year-ago level. Holiday sales outlook
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.